Past studies have raised concerns that a type of osteoporosis drug may boost the risk of unusual bone fractures. Now research suggests this risk may be overstated.

They're designed to strengthen bones. This class of drugs known as bisphosphorates is also prescribed to cancer patients to treat excessive calcium in the blood. These drugs can actually increase the risks of unusual bone fractures.